Morbus diureticus in the elderly: Epidemic overuse of a widely applied group of drugs

Journal of the American Medical Directors Association

Volumn 14, Issue 6, 2013, Pages 437-442

  Wehling, Martin ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Arterial hypertension; Diuretics; Elderly patients; Heart failure

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; POTASSIUM; THIAZIDE DIURETIC AGENT;

ARTICLE; ASTHENIA; BRAIN DAMAGE; CONFUSION; DELIRIUM; DIABETOGENESIS; DISEASE CLASSIFICATION; DRUG ABUSE; DRUG EFFICACY; DRUG OVERDOSE; DRUG SAFETY; ELDERLY CARE; ELECTROLYTE DISTURBANCE; EPIDEMIC; EXTRACELLULAR SPACE; HEART ARRHYTHMIA; HEART FAILURE; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPOKALEMIA; HYPONATREMIA; HYPOVOLEMIA; KIDNEY DYSFUNCTION; MAINTENANCE THERAPY; MEDICAL TERMINOLOGY; METABOLIC DISORDER; MORBUS DIURETICUS; MORTALITY; MUSCLE WEAKNESS; PATIENT COMPLIANCE; PERIPHERAL EDEMA; PREVALENCE; SUDDEN DEATH; URINARY URGENCY; VEIN THROMBOSIS;

EID: 84878841416     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2013.02.002     Document Type: Article

References (67)

1. Plouin P.F., Rossignol P., Bobrie G. Hypertension in the elderly. Bull Acad Natl Med 2006, 190:793-805.
2. Wittchen H.U., Glaesmer H., März W., et al. Cardiovascular risk factors in primary care: Methods and baseline prevalence rates-the DETECT program. Curr Med Res Opin 2005, 21:619-630. Study Group.
3. Lloyd-Jones D., Adams R., Carnethon M., et al. Heart disease and stroke statistics-2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119:480-486.
4. Roger V.L., Go A.S., Lloyd-Jones D.M., et al. Heart disease and stroke statistics-2011 update. A report from the American Heart Association. Circulation 2011, 123:e18-e209.
5. Coresh J., Selvin E., Stevens L.A., et al. Prevalence of chronic kidney disease in the United States. JAMA 2007, 298:2038-2047.
6. Messerli F.H., Makani H., Benjo A., et al. Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring: A meta-analysis of randomized trials. J Am Coll Cardiol 2011, 57:590-600.
7. Hofer-Dueckelmann C., Prinz E., Beindl W., et al. Adverse drug reactions (ADRs) associated with hospital admissions-elderly female patients are at highest risk. Int J Clin Pharmacol Ther 2011, 49:577-586.
8. Kane-Gill S.L., Van Den Bos J., Handler S.M. Adverse drug reactions in hospital and ambulatory care settings identified using a large administrative database. Ann Pharmacother 2010, 44:983-993.
9. Wehling M. Guideline-driven polypharmacy in elderly, multimorbid patients is basically flawed: There are almost no guidelines for these patients. J Am Geriatr Soc 2011, 59:376-377.
10. Wehling M. Who protects physicians and patients from guidelines?. Cardiology 2012, 121:56-58.
11. Inouye S.K., Studenski S., Tinetti M.E., Kuchel G.A. Geriatric syndromes: Clinical, research, and policy implications of a core geriatric concept. J Am Geriatr Soc 2007, 55:780-791.
12. Van den Akker M., Buntinx F., Metsemakers J.F., et al. Multimorbidity in general practice: Prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol 1998, 51:367-375.
13. Kaufman D.W., Kelly J.P., Rosenberg L., et al. Recent patterns of medication use in the ambulatory adult population of the United States: The Slone Survey. JAMA 2002, 287:337-344.
14. Kjeldsen K. Hypokalemia and sudden cardiac death. Exp Clin Cardiol 2010, 15:e96-e99.
15. Franse L.V., Pahor M., Di Bari M., et al. Hypokalemia associated with diuretic use and cardiovascular events in the systolic hypertension in the elderly program. Hypertension 2000, 35:1025-1030.
16. Sunderam S.G., Mankikar G.D. Hyponatraemia in the elderly. Age Ageing 1983, 12:77-80.
17. Hoes A.W., Grobbee D.E., Peet T.M., Lubsen J. Do non-potassium-sparing diuretics increase the risk of sudden cardiac death in hypertensive patients? Recent evidence. Drugs 1994, 47:711-733.
18. Cohen H.W., Madhavan S., Alderman M.H. High and low serum potassium associated with cardiovascular events in diuretic-treated patients. J Hypertens 2001, 19:1315-1323.
19. Siscovick D.S., Raghunathan T.E., Psaty B.M., et al. Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 1994, 330:1852-1857.
20. Ahmed A., Husain A., Love T.E., et al. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: An observational study using propensity score methods. Eur Heart J 2006, 27:1431-1439.
21. Paltiel O., Salakhov E., Ronen I., et al. Management of severe hypokalemia in hospitalized patients: A study of quality of care based on computerized databases. Arch Intern Med 2001, 161:1089-1095.
22. DuBeau C.E., Kiely D.K., Resnick N.M. Quality of life impact of urge incontinence in older persons: A new measure and conceptual structure. J Am Geriatr Soc 1999, 47:989-994.
23. Kokot F., Hyla-Klekot L. Drug-induced abnormalities of potassium metabolism. Pol Arch Med Wewn 2008, 118:431-434.
24. Janssen I., Baumgartner R.N., Ross R., et al. Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol 2004, 159:413-421.
25. Leren P., Helgeland A. Coronary heart disease and treatment of hypertension. Some Oslo Study data. Am J Med 1986, 80:3-6.
26. Berry S.D., Mittleman M.A., Zhang Y., et al. New loop diuretic prescriptions may be an acute risk factor for falls in the nursing home. Pharmacoepidemiol Drug Saf 2012, 21:560-563.
27. Talley N.J., Fleming K.C., Evans J.M., et al. Constipation in an elderly community: A study of prevalence and potential risk factors. Am J Gastroenterol 1996, 91:19-25.
28. Jensen O.B., Mosdal C., Reske-Nielsen E. Hypokalemic myopathy during treatment with diuretics. Acta Neurol Scand 1977, 55:465-482.
29. Leung A.A., Wright A., Pazo V., et al. Risk of thiazide-induced hyponatremia in patients with hypertension. Am J Med 2011, 124:1064-1072.
30. Glover M., Clayton J. Thiazide-induced hyponatraemia: Epidemiology and clues to pathogenesis. Cardiovasc Ther 2012, 30:e219-e226.
31. Oren R.M. Hyponatremia in congestive heart failure. Am J Cardiol 2005, 95:2B-7B.
32. Lee W.H., Packer M. Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation 1986, 73:257-267.
33. Greenberg A. Diuretic complications. Am J Med Sci 2000, 319:10-24.
34. Sonnenblick M., Friedlander Y., Rosin A.J. Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients. Chest 1993, 103:601-606.
35. Francis G.S., Siegel R.M., Goldsmith S.R., et al. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Ann Intern Med 1985, 103:1-6.
36. van Kraaij D.J., Jansen R.W., Sweep F.C., Hoefnagels W.H. Neurohormonal effects of furosemide withdrawal in elderly heart failure patients with normal systolic function. Eur J Heart Fail 2003, 56:47-53.
37. van Kraaij D.J., Jansen R.W., Bouwels L.H., Hoefnagels W.H. Furosemide withdrawal improves postprandial hypotension in elderly heart failure patients with preserved left ventricular systolic function. Arch Intern Med 1999, 159:1599-1605.
38. van Kraaij D.J., Jansen R.W., Bouwels L.H., et al. Furosemide withdrawal in elderly heart failure patients with preserved left ventricular systolic function. Am J Cardiol 2000, 85:1461-1466.
39. Green S.T., Ng J.P., Callaghan M. Metolazone and axillary vein thrombosis. Scott Med J 1988, 33:211-212.
40. Baskurt O.K., Meiselman H.J. Iatrogenic hyperviscosity and thrombosis. Semin Thromb Hemost 2012, 38:854-864.
41. Grimm C., Köberlein J., Wiosna W., et al. New-onset diabetes and antihypertensive treatment. GMS Health Technol Assess 2010, 6:1861-1888.
42. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002, 288:2981-2997. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group.
43. Elliott W.J., Meyer P.M. Incident diabetes in clinical trials of antihypertensive drugs: A network meta-analysis. Lancet 2007, 369:201-207.
44. Bakris G., Molitch M., Hewkin A., et al. Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome. Diabetes Care 2006, 29:2592-2597.
45. Blackburn D.F., Wilson T.W. Antihypertensive medications and blood sugar: Theories and implications. Can J Cardiol 2006, 22:229-233.
46. Zillich A.J., Garg J., Basu S., et al. Thiazide diuretics, potassium, and the development of diabetes: A quantitative review. Hypertension 2006, 48:219-224.
47. Almgren T., Wilhelmsen L., Samuelsson O., et al. Diabetes in treated hypertension is common and carries a high cardiovascular risk: Results from a 28-year follow-up. J Hypertens 2007, 25:1311-1317.
48. Conlin P.R., Gerth W.C., Fox J., et al. Four-year persistence patterns among patients initiating therapy with the angiotensin II receptor antagonist losartan versus other antihypertensive drug classes. Clin Ther 2001, 23:1999-2010.
49. Prandin M.G., Cicero A.F., Veronesi M., et al. Persistence of treatment and blood pressure control with different first-line antihypertensive treatments: A prospective evaluation. Clin Exp Hypertens 2007, 29:553-562.
50. Hasford J., Schröder-Bernhardi D., Rottenkolber M., et al. Persistence with antihypertensive treatments: Results of a 3-year follow-up cohort study. Eur J Clin Pharmacol 2007, 63:1055-1061.
51. Düsing R. Sexual dysfunction in male patients with hypertension: Influence of antihypertensive drugs. Drugs 2005, 65:773-786.
52. Kronish I.M., Woodward M., Sergie Z., et al. Meta-analysis: Impact of drug class on adherence to antihypertensives. Circulation 2011, 123:1611-1621.
53. Wing L.M.H., Reid C.M., Ryan P., et al. A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 2003, 348:583-592.
54. Yusuf S., Teo K.K., et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008, 358:1547-1559. ONTARGET Investigators.
55. Haller H., Ito S., Izzo J.L., et al. Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. N Engl J Med 2011, 364:907-917.
56. Aronow W.S., Fleg J.L., Pepine C.J., et al. ACCF/AHA 2011 Expert Consensus Document on Hypertension in the elderly: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Coll Cardiol 2011, 57:2037-2114.
57. Jamerson K., Weber M.A., Bakris G.L., et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008, 359:2417-2428.
58. Václavík J., Sedlák R., Plachy M., et al. Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): A randomized, double-blind, placebo-controlled trial. Hypertension 2011, 57:1069-1075.
59. Sharabi Y., Adler E., Shamis A., et al. Efficacy of add-on aldosterone receptor blocker in uncontrolled hypertension. Am J Hypertens 2006, 19:750-755.
60. Dinsdale C., Wani M., Steward J., O'Mahony M.S. Tolerability of spironolactone as adjunctive treatment for heart failure in patients over 75 years of age. Age Ageing 2005, 34:395-398.
61. Wehling M. Drug Therapy for the Elderly 2013, Springer, Vienna.
62. Bayliss J., Norell M., Canepa-Anson R., et al. Untreated heart failure: Clinical and neuroendocrine effects of introducing diuretics. Br Heart J 1987, 57:17-22.
63. Ikram H., Chan W., Espiner E.A., Nicholls M.G. Haemodynamic and hormone responses to acute and chronic furosemide therapy in congestive heart failure. Clin Sci 1980, 59:443-447.
64. Galve E., Mallol A., Catalan R., et al. Clinical and neurohumoral consequences of diuretic withdrawal in patients with chronic, stabilized heart failure and systolic dysfunction. Eur J Heart Fail 2005, 7:892-898.
65. Felker G.M., Lee K.L., Bull D.A., et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 2011, 364:797-805.
66. Jentzer J.C., DeWald T.A., Hernandez A.F. Combination of loop diuretics with thiazide-type diuretics in heart failure. J Am Coll Cardiol 2010, 56:1527-1534.
67. Lassen C.K., Jespersen B. Management of diuretic treatment: A challenge in the obese patient. Scand J Urol Nephrol 2011, 45:220-222.